{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:05:10Z","timestamp":1786403110093,"version":"build-2736575974"},"reference-count":57,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["JP21K07428"],"award-info":[{"award-number":["JP21K07428"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["JP22K07508"],"award-info":[{"award-number":["JP22K07508"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22dk0207055h0002"],"award-info":[{"award-number":["22dk0207055h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent evidence suggests a link between glycoprotein non-metastatic melanoma protein B (GPNMB) and Parkinson's disease (PD) pathogenesis. Although elevated plasma GPNMB levels associated with disease severity have been reported in PD, cerebrospinal fluid (CSF) alterations remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore CSF GPNMB alterations and its clinical significance in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study enrolled 118 sporadic PD patients and 40 controls. We examined the potential associations between CSF GPNMB levels and the clinical characteristics or biomarkers of neurodegenerative pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PD patients had higher CSF GPNMB levels than controls (\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0159). In the PD group, CSF GPNMB levels correlated with age (age at examination:\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u20090.2511,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0061; age at onset:\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u20090.2800,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0021) and the severity of motor and cognitive dysfunction (MDS-UPDRS III score:\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u20090.1998,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0347; Mini-Mental State Examination score:\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u2009\u22120.1922,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0370). After correcting for multiple comparisons, the correlation with age at onset remained significant. CSF GPNMB levels were also positively correlated with CSF soluble triggering receptor expressed on myeloid cells 2 (sTREM2) levels in both the PD (\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u20090.3582,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      &lt;\u20090.0001) and control (\n                      <jats:italic toggle=\"yes\">\n                        r\n                        <jats:sub>s\u2009<\/jats:sub>\n                      <\/jats:italic>\n                      =\u20090.4743,\n                      <jats:italic toggle=\"yes\">p\u2009<\/jats:italic>\n                      =\u20090.0023) groups. Furthermore, multiple regression analysis revealed CSF sTREM2 level as the strongest determinant of CSF GPNMB levels in the PD group (t-value\u2009=\u20093.49, p\u2009=\u20090.0007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated CSF GPNMB levels, linked with age and microglial activation, may be a valuable marker for understanding the interplay between aging, neuroinflammation, and PD pathology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x241288712","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T18:42:51Z","timestamp":1733683371000},"page":"1533-1542","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["CSF GPNMB in Parkinson's disease: A potential association with age and microglial activation"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-876X","authenticated-orcid":false,"given":"Xi-Chen","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"},{"name":"Department of Neurology, the Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Wuxi, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-8526","authenticated-orcid":false,"given":"Yasuaki","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Ohdake","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harutsugu","family":"Tatebe","sequence":"additional","affiliation":[{"name":"Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-0123","authenticated-orcid":false,"given":"Sayuri","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-3011","authenticated-orcid":false,"given":"Akihiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,8]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"e_1_3_5_3_2","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey ER","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 2018; 8: S3\u2013S8.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv236"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2018.07.004"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.08.013"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk0637"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.5257"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00461-9"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1235840"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00952"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-017-0514-8"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1100-1"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12078"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.12.002"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120194"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00221-2"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0612-3"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110020"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42505-x"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00374-8"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa021"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191120"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2021.02.024"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11875-z"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00447-7"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21844"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29410"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12375"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51022"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200344"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3088-1"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674739"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136300"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-020-01921-6"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0707-z"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab446"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002461"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006737"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04356-8"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23469"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183359.50822.f2"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10522-3"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23620-z"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105630"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141732"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2021.06.030"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160844"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-019-01424-7"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.892493"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.032"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106001"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29566"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.3180"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241288712","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X241288712","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241288712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:07:35Z","timestamp":1780682855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X241288712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1177\/1877718X241288712"],"URL":"https:\/\/doi.org\/10.1177\/1877718x241288712","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}